Suprabhat Giri , Sarat Chandra Panigrahi , Vedavyas Mohapatra , Preetam Nath , Saroj K. Sahu , Bipadabhanjan Mallick , Dibya L. Praharaj , Anil C. Anand
{"title":"Comparison of Vascular Complications Between Living-donor and Deceased-donor Liver Transplantation – A Systematic Review and Meta-analysis","authors":"Suprabhat Giri , Sarat Chandra Panigrahi , Vedavyas Mohapatra , Preetam Nath , Saroj K. Sahu , Bipadabhanjan Mallick , Dibya L. Praharaj , Anil C. Anand","doi":"10.1016/j.jceh.2024.102414","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Vascular complications commonly cause graft loss and morbidity after liver transplantation (LT). Comparative data on the risk of vascular complications are limited. Hence, the present meta-analysis was conducted to analyze the difference in vascular complications between living-donor LT (LDLT) and deceased-donor LT (DDLT).</div></div><div><h3>Methods</h3><div>A literature search of three databases was conducted for studies comparing the incidence of vascular complications with LDLT and DDLT. The event rates and odds ratios (OR) with 95% confidence intervals (CI) were calculated using a random-effects model.</div></div><div><h3>Results</h3><div>A total of 20 studies were included in the final analysis. There was no difference in the incidence of overall vascular complications (9.3%, 95% CI: 6.6–12.0 vs. 8.5%, 95% CI: 5.6–11.4) between LDLT and DDLT with OR 0.94 (95% CI: 0.73–1.21) (15 studies).There was a higher incidence of vascular complications with LDLT in older studies (published before 2013) but not in new studies. When comparing the individual complications, LDLT was associated with a higher incidence of hepatic artery thrombosis (HAT) (3.8%, 95% CI: 2.4–5.2 vs. 1.6%, 95% CI: 1.1–2.2)with OR 2.20 (95% CI: 1.53–3.17) (14 studies)and a significantly lower incidence of intra-abdominal bleeding(4.8%, 95% CI: 3.3–6.2 vs. 7.9%, 95% CI: 5.0–10.7) with OR 0.64 (95% CI: 0.47–0.87) (11 studies). However, there was no difference in the incidence (2.1%, 95% CI: 0.5–3.8 vs. 1.0%, 95% CI: 0.1–1.9) of portal vein thrombosis between LDLT and DDLT with OR 1.85 (95% CI: 0.82–4.18) (6 studies).</div></div><div><h3>Conclusion</h3><div>Despite a comparable risk of vascular complications between LDLT and DDLT, LDLT was associated with a higher risk of HAT and a lower risk of intraprocedural bleeding. Further studies are required to analyze the effect of donor-recipient characteristics and surgical techniques on the risk of vascular complications.</div></div>","PeriodicalId":15479,"journal":{"name":"Journal of Clinical and Experimental Hepatology","volume":"15 1","pages":"Article 102414"},"PeriodicalIF":3.3000,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0973688324010818","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Vascular complications commonly cause graft loss and morbidity after liver transplantation (LT). Comparative data on the risk of vascular complications are limited. Hence, the present meta-analysis was conducted to analyze the difference in vascular complications between living-donor LT (LDLT) and deceased-donor LT (DDLT).
Methods
A literature search of three databases was conducted for studies comparing the incidence of vascular complications with LDLT and DDLT. The event rates and odds ratios (OR) with 95% confidence intervals (CI) were calculated using a random-effects model.
Results
A total of 20 studies were included in the final analysis. There was no difference in the incidence of overall vascular complications (9.3%, 95% CI: 6.6–12.0 vs. 8.5%, 95% CI: 5.6–11.4) between LDLT and DDLT with OR 0.94 (95% CI: 0.73–1.21) (15 studies).There was a higher incidence of vascular complications with LDLT in older studies (published before 2013) but not in new studies. When comparing the individual complications, LDLT was associated with a higher incidence of hepatic artery thrombosis (HAT) (3.8%, 95% CI: 2.4–5.2 vs. 1.6%, 95% CI: 1.1–2.2)with OR 2.20 (95% CI: 1.53–3.17) (14 studies)and a significantly lower incidence of intra-abdominal bleeding(4.8%, 95% CI: 3.3–6.2 vs. 7.9%, 95% CI: 5.0–10.7) with OR 0.64 (95% CI: 0.47–0.87) (11 studies). However, there was no difference in the incidence (2.1%, 95% CI: 0.5–3.8 vs. 1.0%, 95% CI: 0.1–1.9) of portal vein thrombosis between LDLT and DDLT with OR 1.85 (95% CI: 0.82–4.18) (6 studies).
Conclusion
Despite a comparable risk of vascular complications between LDLT and DDLT, LDLT was associated with a higher risk of HAT and a lower risk of intraprocedural bleeding. Further studies are required to analyze the effect of donor-recipient characteristics and surgical techniques on the risk of vascular complications.